SPN-817 (BIS-001ER, Huperzine)

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

New Drugs in Development

Phase Of Development

Phase 1

Sponsors and Collaborators

Supernus; Biscayne Phramceuticals, EF, MFF

Mechanism of Action

Acetylcholine

Mechanism Description

inhibits the acetylcholinesterase enzyme

Populations Tested In

Adult Focal Impaired Awareness Seizures

Other Resources

Special FDA Designation

Nonprofit or Government Support

Nonprofit

Nonprofit or Government Support Description

Epilepsy Foundation - NTCG 2006

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.